A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has missed its primary endpoint. But, with patients improving on multiple secondary endpoints, the biotech is accelerating ...

While the public One UI 8.5 beta has remained exclusive to the Galaxy S25 series so far, Samsung has been actively testing the latest build internally on other Galaxy devices. In recent weeks, One UI ...

I've evaluated outdoor and fitness equipment for over five years. Walking shoes are obviously made for walking, but they aren’t exclusively for daily strolls. Whether you’re running errands, working ...